252 related articles for article (PubMed ID: 25244980)
1. Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and the susceptibility to breast cancer: a meta-analysis.
Lee YH; Song GG
Neoplasma; 2014; 61(5):607-16. PubMed ID: 25244980
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer: a meta-analysis.
Song GG; Lee YH
Immunol Invest; 2013; 42(7):661-72. PubMed ID: 24004063
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor ApaI, TaqI, BsmI, and FokI polymorphisms and psoriasis susceptibility: a meta-analysis.
Lee YH; Choi SJ; Ji JD; Song GG
Mol Biol Rep; 2012 Jun; 39(6):6471-8. PubMed ID: 22290287
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor gene FokI, TaqI, BsmI, and ApaI polymorphisms and susceptibility to pulmonary tuberculosis: a meta-analysis.
Lee YH; Song GG
Genet Mol Res; 2015 Aug; 14(3):9118-29. PubMed ID: 26345844
[TBL] [Abstract][Full Text] [Related]
5. Associations among four polymorphisms (BsmI, FokI, TaqI and ApaI) of vitamin D receptor gene and end-stage renal disease: a meta-analysis.
Yang L; Wu L; Fan Y; Ma J
Arch Med Res; 2015 Jan; 46(1):1-7. PubMed ID: 25434518
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor FokI, TaqI, and ApaI polymorphisms and susceptibility to systemic lupus erythematosus: an updated meta-analysis.
Bae SC; Lee YH
Clin Rheumatol; 2018 Jun; 37(6):1529-1537. PubMed ID: 29468338
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor gene FokI but not TaqI, ApaI, BsmI polymorphism is associated with Hashimoto's thyroiditis: a meta-analysis.
Wang X; Cheng W; Ma Y; Zhu J
Sci Rep; 2017 Jan; 7():41540. PubMed ID: 28134349
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor ApaI, TaqI, BsmI, and FokI polymorphisms and psoriasis susceptibility: an updated meta-analysis.
Lee YH
Clin Exp Dermatol; 2019 Jul; 44(5):498-505. PubMed ID: 30474246
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor TaqI, BsmI and ApaI polymorphisms and osteoarthritis susceptibility: a meta-analysis.
Lee YH; Woo JH; Choi SJ; Ji JD; Song GG
Joint Bone Spine; 2009 Mar; 76(2):156-61. PubMed ID: 19073371
[TBL] [Abstract][Full Text] [Related]
10. Association between vitamin D receptor polymorphisms and vitiligo susceptibility: An updated meta-analysis.
Lee YH; Song GG
J Cosmet Dermatol; 2023 Mar; 22(3):969-979. PubMed ID: 36254395
[TBL] [Abstract][Full Text] [Related]
11. BsmI, TaqI, ApaI and FokI polymorphisms in the vitamin D receptor (VDR) gene and the risk of osteoporosis: a meta-analysis.
Zintzaras E; Rodopoulou P; Koukoulis GN
Dis Markers; 2006; 22(5-6):317-26. PubMed ID: 17264402
[TBL] [Abstract][Full Text] [Related]
12. Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.
Lee YH; Bae SC; Choi SJ; Ji JD; Song GG
Mol Biol Rep; 2011 Aug; 38(6):3643-51. PubMed ID: 21110115
[TBL] [Abstract][Full Text] [Related]
13. ApaI, BsmI, FokI and TaqI polymorphisms in the vitamin D receptor (VDR) gene and the risk of psoriasis: a meta-analysis.
Liu JL; Zhang SQ; Zeng HM
J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):739-46. PubMed ID: 22540341
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D receptor FokI, BsmI, TaqI, ApaI, and EcoRV polymorphisms and susceptibility to melanoma: a meta-analysis.
Lee YH; Gyu Song G
J BUON; 2015; 20(1):235-43. PubMed ID: 25778322
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and meta-analysis on vitamin D receptor polymorphisms and cancer risk.
Xu Y; He B; Pan Y; Deng Q; Sun H; Li R; Gao T; Song G; Wang S
Tumour Biol; 2014 May; 35(5):4153-69. PubMed ID: 24408013
[TBL] [Abstract][Full Text] [Related]
16. Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder.
Coşkun S; Şimşek Ş; Camkurt MA; Çim A; Çelik SB
Gene; 2016 Aug; 588(2):109-14. PubMed ID: 27155524
[TBL] [Abstract][Full Text] [Related]
17. Associations between vitamin D receptor polymorphisms and breast cancer risk.
Wang J; He Q; Shao YG; Ji M; Bao W
Tumour Biol; 2013 Dec; 34(6):3823-30. PubMed ID: 23900677
[TBL] [Abstract][Full Text] [Related]
18. VDR gene FokI polymorphism as a poor prognostic factor for papillary thyroid cancer.
Beysel S; Eyerci N; Pinarli FA; Apaydin M; Kizilgul M; Caliskan M; Ozcelik O; Kan S; Cakal E
Tumour Biol; 2018 Nov; 40(11):1010428318811766. PubMed ID: 30486759
[TBL] [Abstract][Full Text] [Related]
19. The Relationship Between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms.
Baykan O; Akgul M; Uren N; Yaman A; Tinay I; Ergul E; Sazci A; Turkeri L; Haklar G
Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969078
[TBL] [Abstract][Full Text] [Related]
20. The VDR gene FokI polymorphism is associated with gestational diabetes mellitus in Turkish women.
Apaydın M; Beysel S; Eyerci N; Pinarli FA; Ulubay M; Kizilgul M; Ozdemir O; Caliskan M; Cakal E
BMC Med Genet; 2019 May; 20(1):82. PubMed ID: 31096931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
